US Patent 7521455 Fused ring 4-oxopyrimidine derivative
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Akio Kanatani0
Nagaaki Sato0
Shigeru Tokita0
Tsuyoshi Nagase0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+326 characters)
Article
Patent abstract
The present invention provides a compound represented by formula (I) below, or a pharmaceutically acceptable salt thereof, which, having histamine H3 receptor antagonist or inverse agonist activity, is useful in the prophylaxis or therapy of metabolic diseases, circulatory diseases, or nervous system diseases.
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07521455 Fused ring 4-oxopyrimidine derivative US Patent 7521455 Fused ring 4-oxopyrimidine derivative
Infobox
Patent Number
075214550
Patent Number
75214550
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
075214550
Date of Patent
April 21, 2009
0Patent Application Number
110584440
Date Filed
February 14, 2005
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07521455 Fused ring 4-oxopyrimidine derivative
Infobox
Is a
Patent jurisdiction
Patent number
07521455
Date of patent
April 21, 2009
Patent application number
11058444
Date Filed
February 14, 2005
Patent primary examiner
Find more entities like US Patent 7521455 Fused ring 4-oxopyrimidine derivative
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
